Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07116460 · ClinicalTrials.gov registry record · NA

Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma Morbidity

A NA study, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
55
Enrollment target

NCT07116460 is a NA study that is actively recruiting participants, run by Columbia University. The registered enrollment target is 55 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07116460, a NA study, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
55 participants
Enrollment target

Study Summary

This project will investigate the effectiveness of HEPA air cleaners in reducing indoor air pollution and improving asthma morbidity in children living in East Harlem, New York City (NYC). The study will be conducted over a 2-year period. Columbia University and Little Sisters of the Assumption Family Health Service (LSAFHS) will conduct an intervention study to evaluate the efficacy of using a cost-effective high-capacity high efficiency particulate air (HEPA) filter air cleaner to reduce airborne particulate matter (PM) in the homes of children with asthma and to reduce their asthma morbidity. The study will take place in East Harlem, a low-income neighborhood with high asthma prevalence. It will build on findings from prior Housing and Urban Development Lead and Healthy Homes Technical Studies (HUD LHHTS)-funded research, the experience of LSAFHS installing air cleaners in the homes of asthmatic children, and recent findings demonstrating the effectiveness of home air cleaners in reducing asthma morbidity. The investigators hypothesize that the cost-effective single air cleaner will substantially reduce PM exposure in the homes of asthmatic children and reduce airway inflammation and asthma morbidity. This study will use cutting-edge air sampling technology to continuously quantify and characterize indoor air pollutants in the home for one year, verify and incentivize compliance, and conduct repeated exhaled nitric oxide and pulmonary function tests before and throughout the year after the intervention. This cost-effective intervention can be easily and quickly implemented in homes in low-income, urban communities and easily transferred between homes if families move.

Interventions

  • DEVICE Austin Air Cleaner

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2026-01-30
Est. Completion 2028-04
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT07116460

The ClinicalTrials.gov registry entry for NCT07116460 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Austin Air Cleaner is the first listed.

NCT07116460 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07116460 about?

NCT07116460 is a clinical study titled "Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma Morbidity". This project will investigate the effectiveness of HEPA air cleaners in reducing indoor air pollution and improving asthma morbidity in children living in East Harlem, New York City (NYC). The study will be conducted over a 2-year period. Columbia University and Little Sisters of the Assumption Fam...

What is the current status of trial NCT07116460?

This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2026-01-30. Estimated completion is 2028-04.

What interventions are being tested in trial NCT07116460?

The interventions under investigation include: Austin Air Cleaner (DEVICE).

Who is sponsoring clinical trial NCT07116460?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.